Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
imf-001 (2 trials)
Esophageal Neoplasms (Phase 1)
Neoplasms (Phase 1)
Trials (2 total)
Trial APIs (1 total)